Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental?
, , y
09 ago 2021
Acerca de este artículo
Categoría del artículo: Research Article
Publicado en línea: 09 ago 2021
Páginas: 74 - 81
Recibido: 04 ago 2020
Aceptado: 21 sept 2020
DOI: https://doi.org/10.2478/fco-2021-0014
Palabras clave
© 2021 Taoreed Adegoke Azeez et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Azeez, Taoreed Adegoke
Endocrinology, Metabolism and Diabetes Unit, Department of Medicine, University College HospitalIbadan, Nigeria
Folorunso, Sharif Adeniyi
Department of Radiation Oncology, University College HospitalIbadan, Nigeria
Eguzozie, Chinedu
Endocrinology, Metabolism and Diabetes Unit, Department of Medicine, University College HospitalIbadan, Nigeria
Adegboyega, Adeleke Adedapo
Department of Clinical Pharmacology, University College HospitalIbadan, Nigeria